| Literature DB >> 35046096 |
Dwight V Nissley1, Frank McCormick2.
Abstract
SUMMARY: The RAS Initiative was launched in 2013 to address unmet clinical needs of patients with KRAS-driven cancers. The Initiative is based at Frederick National Laboratory for Cancer Research in Frederick, MD, and involves multiple collaborations with the RAS research community in academia and industry with the shared goal of developing RAS therapies. ©2022 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35046096 DOI: 10.1158/2159-8290.CD-21-1554
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397